Molecular analyses and prognostic relevance of HPV in head and neck tumours

Gianna Badaracco, Consuelo Rizzo, Barbara Mafera, Barbara Pichi, Diana Giannarelli, Siavash S. Rahimi, Maurizio G. Vigili, Aldo Venuti

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

HPV involvement in head and neck (HN) cancer is still under active investigation. Fresh frozen and archival clinical samples from 115 patients affected by HN carcinomas were analysed by PCR-based methods and direct sequencing. HPV types, intra-type variants, physical status, viral load and viral transcript presence were determined. HPV positivity was correlated with the main clinical-pathological features, including smoker and drinker status, and the clinical outcome. Twenty-one tumours were HPV positive (18.3%) with HPV16 being the most frequent type (n=14) followed by HPV6 (n=4), HPV33, HPV35, and HPV58 (n=1, each type). Tonsil carcinomas contained more high-risk HPV types (6/8; 75%) than all other sites (p=0.0004). HPV16 genome was integrated in all analysed tumours, as pure integrated form or mixed with concomitant episomal forms (4 cases). The viral load showed a wide variability (range, 0.7-485 copies per cell) with the highest value detected in a larynx tumour and the lowest one in a case of cancer of the oral cavity. In 9 HPV-positive samples where mRNA was available, transcripts of viral early oncogenes originating by integrated, episomal or mixed forms of the viral genome were found. A statistically significant correlation was evidenced between HPV and tumour differentiation, being the virus more associated with tumour grade G3/G4. Multivariate Cox regression analysis revealed that lymph-node and grade status were significant independent factors for a worse disease-free survival and overall survival, whereas the HPV status was associated with a better overall survival (OR, 0.33; 95% CI, 0.13-0.81; p=0.01). Taken together these results indicate that distinct pathological mechanisms for the malignant transformation in each single HN subsite should be taken in account; HPV molecular analyses should be considered a valid tool to distinguish subsets of oropharyngeal tumours and HPV presence could be useful for the prognostic assessment of HNSCC.

Original languageEnglish
Pages (from-to)931-939
Number of pages9
JournalOncology Reports
Volume17
Issue number4
Publication statusPublished - Apr 2007

Fingerprint

Neck
Head
Neoplasms
Viral Load
Human papillomavirus 6
Carcinoma
Viral Genome
Mouth Neoplasms
Palatine Tonsil
Head and Neck Neoplasms
Larynx
Oncogenes
Disease-Free Survival
Mouth
Lymph Nodes
Regression Analysis
Genome
Viruses
Polymerase Chain Reaction
Messenger RNA

Keywords

  • E6/E7 transcription
  • Head and neck tumour
  • HPV
  • Integration
  • Prognosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Badaracco, G., Rizzo, C., Mafera, B., Pichi, B., Giannarelli, D., Rahimi, S. S., ... Venuti, A. (2007). Molecular analyses and prognostic relevance of HPV in head and neck tumours. Oncology Reports, 17(4), 931-939.

Molecular analyses and prognostic relevance of HPV in head and neck tumours. / Badaracco, Gianna; Rizzo, Consuelo; Mafera, Barbara; Pichi, Barbara; Giannarelli, Diana; Rahimi, Siavash S.; Vigili, Maurizio G.; Venuti, Aldo.

In: Oncology Reports, Vol. 17, No. 4, 04.2007, p. 931-939.

Research output: Contribution to journalArticle

Badaracco, G, Rizzo, C, Mafera, B, Pichi, B, Giannarelli, D, Rahimi, SS, Vigili, MG & Venuti, A 2007, 'Molecular analyses and prognostic relevance of HPV in head and neck tumours', Oncology Reports, vol. 17, no. 4, pp. 931-939.
Badaracco G, Rizzo C, Mafera B, Pichi B, Giannarelli D, Rahimi SS et al. Molecular analyses and prognostic relevance of HPV in head and neck tumours. Oncology Reports. 2007 Apr;17(4):931-939.
Badaracco, Gianna ; Rizzo, Consuelo ; Mafera, Barbara ; Pichi, Barbara ; Giannarelli, Diana ; Rahimi, Siavash S. ; Vigili, Maurizio G. ; Venuti, Aldo. / Molecular analyses and prognostic relevance of HPV in head and neck tumours. In: Oncology Reports. 2007 ; Vol. 17, No. 4. pp. 931-939.
@article{531611d19a9f4c28bd233ea96055a5ba,
title = "Molecular analyses and prognostic relevance of HPV in head and neck tumours",
abstract = "HPV involvement in head and neck (HN) cancer is still under active investigation. Fresh frozen and archival clinical samples from 115 patients affected by HN carcinomas were analysed by PCR-based methods and direct sequencing. HPV types, intra-type variants, physical status, viral load and viral transcript presence were determined. HPV positivity was correlated with the main clinical-pathological features, including smoker and drinker status, and the clinical outcome. Twenty-one tumours were HPV positive (18.3{\%}) with HPV16 being the most frequent type (n=14) followed by HPV6 (n=4), HPV33, HPV35, and HPV58 (n=1, each type). Tonsil carcinomas contained more high-risk HPV types (6/8; 75{\%}) than all other sites (p=0.0004). HPV16 genome was integrated in all analysed tumours, as pure integrated form or mixed with concomitant episomal forms (4 cases). The viral load showed a wide variability (range, 0.7-485 copies per cell) with the highest value detected in a larynx tumour and the lowest one in a case of cancer of the oral cavity. In 9 HPV-positive samples where mRNA was available, transcripts of viral early oncogenes originating by integrated, episomal or mixed forms of the viral genome were found. A statistically significant correlation was evidenced between HPV and tumour differentiation, being the virus more associated with tumour grade G3/G4. Multivariate Cox regression analysis revealed that lymph-node and grade status were significant independent factors for a worse disease-free survival and overall survival, whereas the HPV status was associated with a better overall survival (OR, 0.33; 95{\%} CI, 0.13-0.81; p=0.01). Taken together these results indicate that distinct pathological mechanisms for the malignant transformation in each single HN subsite should be taken in account; HPV molecular analyses should be considered a valid tool to distinguish subsets of oropharyngeal tumours and HPV presence could be useful for the prognostic assessment of HNSCC.",
keywords = "E6/E7 transcription, Head and neck tumour, HPV, Integration, Prognosis",
author = "Gianna Badaracco and Consuelo Rizzo and Barbara Mafera and Barbara Pichi and Diana Giannarelli and Rahimi, {Siavash S.} and Vigili, {Maurizio G.} and Aldo Venuti",
year = "2007",
month = "4",
language = "English",
volume = "17",
pages = "931--939",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Molecular analyses and prognostic relevance of HPV in head and neck tumours

AU - Badaracco, Gianna

AU - Rizzo, Consuelo

AU - Mafera, Barbara

AU - Pichi, Barbara

AU - Giannarelli, Diana

AU - Rahimi, Siavash S.

AU - Vigili, Maurizio G.

AU - Venuti, Aldo

PY - 2007/4

Y1 - 2007/4

N2 - HPV involvement in head and neck (HN) cancer is still under active investigation. Fresh frozen and archival clinical samples from 115 patients affected by HN carcinomas were analysed by PCR-based methods and direct sequencing. HPV types, intra-type variants, physical status, viral load and viral transcript presence were determined. HPV positivity was correlated with the main clinical-pathological features, including smoker and drinker status, and the clinical outcome. Twenty-one tumours were HPV positive (18.3%) with HPV16 being the most frequent type (n=14) followed by HPV6 (n=4), HPV33, HPV35, and HPV58 (n=1, each type). Tonsil carcinomas contained more high-risk HPV types (6/8; 75%) than all other sites (p=0.0004). HPV16 genome was integrated in all analysed tumours, as pure integrated form or mixed with concomitant episomal forms (4 cases). The viral load showed a wide variability (range, 0.7-485 copies per cell) with the highest value detected in a larynx tumour and the lowest one in a case of cancer of the oral cavity. In 9 HPV-positive samples where mRNA was available, transcripts of viral early oncogenes originating by integrated, episomal or mixed forms of the viral genome were found. A statistically significant correlation was evidenced between HPV and tumour differentiation, being the virus more associated with tumour grade G3/G4. Multivariate Cox regression analysis revealed that lymph-node and grade status were significant independent factors for a worse disease-free survival and overall survival, whereas the HPV status was associated with a better overall survival (OR, 0.33; 95% CI, 0.13-0.81; p=0.01). Taken together these results indicate that distinct pathological mechanisms for the malignant transformation in each single HN subsite should be taken in account; HPV molecular analyses should be considered a valid tool to distinguish subsets of oropharyngeal tumours and HPV presence could be useful for the prognostic assessment of HNSCC.

AB - HPV involvement in head and neck (HN) cancer is still under active investigation. Fresh frozen and archival clinical samples from 115 patients affected by HN carcinomas were analysed by PCR-based methods and direct sequencing. HPV types, intra-type variants, physical status, viral load and viral transcript presence were determined. HPV positivity was correlated with the main clinical-pathological features, including smoker and drinker status, and the clinical outcome. Twenty-one tumours were HPV positive (18.3%) with HPV16 being the most frequent type (n=14) followed by HPV6 (n=4), HPV33, HPV35, and HPV58 (n=1, each type). Tonsil carcinomas contained more high-risk HPV types (6/8; 75%) than all other sites (p=0.0004). HPV16 genome was integrated in all analysed tumours, as pure integrated form or mixed with concomitant episomal forms (4 cases). The viral load showed a wide variability (range, 0.7-485 copies per cell) with the highest value detected in a larynx tumour and the lowest one in a case of cancer of the oral cavity. In 9 HPV-positive samples where mRNA was available, transcripts of viral early oncogenes originating by integrated, episomal or mixed forms of the viral genome were found. A statistically significant correlation was evidenced between HPV and tumour differentiation, being the virus more associated with tumour grade G3/G4. Multivariate Cox regression analysis revealed that lymph-node and grade status were significant independent factors for a worse disease-free survival and overall survival, whereas the HPV status was associated with a better overall survival (OR, 0.33; 95% CI, 0.13-0.81; p=0.01). Taken together these results indicate that distinct pathological mechanisms for the malignant transformation in each single HN subsite should be taken in account; HPV molecular analyses should be considered a valid tool to distinguish subsets of oropharyngeal tumours and HPV presence could be useful for the prognostic assessment of HNSCC.

KW - E6/E7 transcription

KW - Head and neck tumour

KW - HPV

KW - Integration

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=34249302182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249302182&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 931

EP - 939

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 4

ER -